SCHEMBL4782373

SCHEMBL4782373

Cc1cc(O)ccc1C(=O)CCCn1ccnn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
RAB9A P51151 4/20 0.36
NPC1 O15118 3/20 0.36
PDGFRB P09619 1/20 0.34
KDR P35968 1/20 0.34
ALDH1A1 P00352 5/20 0.34
KMT2A Q03164 3/20 0.33
TP53 P04637 2/20 0.33
HSD17B3 P37058 2/20 0.33
LMNA P02545 1/20 0.33
P4HB P07237 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
PAX8 Q06710 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HSP90AB1 P08238 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 2/20 0.33
POLB P06746 1/20 0.32
CHRM2 P08172 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4731198 0.84 HTT (0.54) HTTRAB9ANPC1ALDH1A1KMT2A
SCHEMBL4783039 0.81 RAB9A (0.54) RAB9ANPC1ALDH1A1HSD17B3POLB
SCHEMBL4599537 0.75 TYR (0.37) HTTPDGFRBKDRALDH1A1KMT2A
SCHEMBL4783529 0.72 PDE4B (0.54) HTTRAB9ANPC1ALDH1A1KMT2A
SCHEMBL10065555 0.70 FOLH1 (0.37) LMNATSHRSMN1; SMN2
SCHEMBL5042822 0.69 KDR (0.33) NPC1PDGFRBKDRALDH1A1KMT2A
SCHEMBL8019351 0.69 HTT (0.64) HTTRAB9ANPC1ALDH1A1KMT2A
SCHEMBL27502289 0.69 HTT (0.46) HTTRAB9ANPC1ALDH1A1KMT2A
SCHEMBL4606260 0.68 PDGFRB (0.33) PDGFRBKDRHSD17B3
SCHEMBL5440246 0.68 TBXAS1 (0.42) LMNATSHRMAPK1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008034579-A1 2-HETEROCYCLYL-5-PHENOXYMETHYLPYRIDINE DERIVATIVES AS ANTICANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 WO disclosed